|
|
|
Volumn 8, Issue 3, 2002, Pages 243-250
|
|
Changes in related drug class utilization after market withdrawal of cisapride
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIMETIDINE;
CISAPRIDE;
FAMOTIDINE;
GASTROINTESTINAL AGENT;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
METOCLOPRAMIDE;
NIZATIDINE;
OMEPRAZOLE;
PROKINETIC AGENT;
PROTON PUMP INHIBITOR;
RANITIDINE;
AGED;
ARTICLE;
COHORT ANALYSIS;
DISEASE SEVERITY;
DRUG COST;
DRUG MARKETING;
DRUG UTILIZATION;
DRUG WITHDRAWAL;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL DISEASE;
GERIATRIC CARE;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
LONGITUDINAL STUDY;
MAJOR CLINICAL STUDY;
MALE;
MANAGED CARE;
PRESCRIPTION;
PREVALENCE;
PRIORITY JOURNAL;
REIMBURSEMENT;
RETROSPECTIVE STUDY;
SIDE EFFECT;
AGED;
AGED, 80 AND OVER;
ANALYSIS OF VARIANCE;
CISAPRIDE;
DRUG AND NARCOTIC CONTROL;
DRUG UTILIZATION REVIEW;
FEMALE;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL AGENTS;
HEALTH EXPENDITURES;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
INSURANCE, PHARMACEUTICAL SERVICES;
LONGITUDINAL STUDIES;
MALE;
NEW JERSEY;
PRODUCT SURVEILLANCE, POSTMARKETING;
STATE HEALTH PLANS;
UNITED STATES;
|
|
EID: 0036209709
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (22)
|
|
References (16)
|
